Prosecution Insights
Last updated: April 19, 2026

National Institutes Of Biomedical Innovation Health And Nutrition

7 pending office actions

Portfolio Summary

7
Total Pending OAs
2
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18265617 OPTIC NERVE PROTECTING AGENT CONTAINING ANTI-LRP1 ANTIBODY FONTAINHAS, AURORA M 1675 Non-Final OA Jun 06, 2023
17905442 PREVENTION OR TREATMENT OF ANEURYSMS USING MIR-33B INHIBITOR CHONG, KIMBERLY 1636 Non-Final OA Sep 01, 2022
17789402 METHOD AND SYSTEM FOR ESTIMATING RENAL FUNCTION FRUMKIN, JESSE P 1685 Non-Final OA Jun 27, 2022
17789399 D-SERINE TRANSPORT MODIFIER AND SCREENING METHOD THEREOF, AND SCREENING METHOD OF D-SERINE TRANSPORTER PROTEIN SZNAIDMAN, MARCOS L 1628 Non-Final OA Jun 27, 2022
17776743 NUCLEIC ACID LIPID PARTICLE VACCINE ENCAPSULATING HPV MRNA STEINKE, SEAN JAMES 1619 Final Rejection May 13, 2022
17638723 MOLECULAR TARGETED NUCLEIC ACID MEDICINE FOR GASTRIC CANCER CHONG, KIMBERLY 1636 Final Rejection Feb 25, 2022
17605656 METHOD FOR DIAGNOSING ENDOMETRIOSIS, DISEASE STATE MONITORING METHOD, AND KIT EMCH, GREGORY S 1678 Non-Final OA Oct 22, 2021

Managing National Institutes Of Biomedical Innovation Health And Nutrition's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month